Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales

Ambler, 1980, The structure of β-lactamases, Philos Trans R Soc Lond B Biol Sci, 289, 321, 10.1098/rstb.1980.0049 Walther-Rasmussen, 2004, Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases, Can J Microbiol, 50, 137, 10.1139/w03-111 Poirel, 2002, Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3, J Antimicrob Chemother, 50, 1031, 10.1093/jac/dkf240 Bonnet, 2004, Growing group of extended-spectrum β-lactamases: the CTX-M enzymes, Antimicrob Agents Chemother, 48, 1, 10.1128/AAC.48.1.1-14.2004 Lartigue, 2004, Diversity of genetic environment of blaCTX-M genes, FEMS Microbiol Lett, 234, 201, 10.1111/j.1574-6968.2004.tb09534.x Weldhagen, 2004, Integrons and β-lactamases—a novel perspective on resistance, Int J Antimicrob Agents, 23, 556, 10.1016/j.ijantimicag.2004.03.007 Philippon, 2002, Plasmid-determined AmpC-type β-lactamases, Antimicrob Agents Chemother, 46, 1, 10.1128/AAC.46.1.1-11.2002 Pérez-Pérez, 2002, Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR, J Clin Microbiol, 40, 2153, 10.1128/JCM.40.6.2153-2162.2002 Caroff, 2000, Analysis of the effects of −42 and −32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC, J Antimicrob Chemother, 45, 783, 10.1093/jac/45.6.783 Liebana, 2004, Characterization of β-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom, Microb Drug Resist, 10, 1, 10.1089/107662904323047745 Mulvey, 2005, Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals, Antimicrob Agents Chemother, 49, 358, 10.1128/AAC.49.1.358-365.2005 Frost, 1994, Testing for resistance to antimicrobial drugs, 73 National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th ed. Approved Standard M-100-S9. Document M31-A. Wayne, PA: NCCLS; 1999. Batchelor, 2005, blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003, Antimicrob Agents Chemother, 49, 1319, 10.1128/AAC.49.4.1319-1322.2005 Hopkins, 2006, Novel plasmid-mediated CTX-M-8 subgroup extended-spectrum β-lactamase (CTX-M-40) isolated in the UK, Int J Antimicrob Agents, 27, 572, 10.1016/j.ijantimicag.2006.03.003 Caroff, 2000, Analysis of the effects of −42 and −32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC, J Antimicrob Chemother, 45, 783, 10.1093/jac/45.6.783 Sabaté, 2002, Novel complex sul1-type integron in Escherichia coli carrying blaCTX-M-9, Antimicrob Agents Chemother, 46, 2656, 10.1128/AAC.46.8.2656-2661.2002 Powell, 1994, Subdivision of Salmonella enteritidis PT 4 by pulsed-field gel electrophoresis: potential for epidemiological surveillance, FEMS Microbiol Lett, 119, 193, 10.1111/j.1574-6968.1994.tb06888.x Centers for Disease Control and Prevention. Standardized molecular subtyping of foodborne bacterial pathogens by pulsed-field gel electrophoresis. Atlanta, GA: CDC; 2002. Woodford, 2004, Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK, J Antimicrob Chemother, 54, 735, 10.1093/jac/dkh424 Birnboim, 1979, A rapid alkaline extraction procedure for screening recombinant plasmid DNA, Nucleic Acids Res, 7, 1513, 10.1093/nar/7.6.1513 Alobwede, 2003, CTX-M extended-spectrum β-lactamase arrives in the UK, J Antimicrob Chemother, 51, 470, 10.1093/jac/dkg096 Munday, 2004, Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK, J Antimicrob Chemother, 54, 628, 10.1093/jac/dkh397 Chmelnitsky, 2005, CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel, Antimicrob Agents Chemother, 49, 4745, 10.1128/AAC.49.11.4745-4750.2005 Poirel, 2003, Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene, Antimicrob Agents Chemother, 47, 2938, 10.1128/AAC.47.9.2938-2945.2003 Di Conza, 2002, Novel class 1 integron (InS21) carrying blaCTX-M-2 in Salmonella enterica serovar Infantis, Antimicrob Agents Chemother, 46, 2257, 10.1128/AAC.46.7.2257-2261.2002 Arduino, 2002, blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513, Antimicrob Agents Chemother, 46, 2303, 10.1128/AAC.46.7.2303-2306.2002 Power, 2005, Description of In116, the first blaCTX-M-2-containing complex class 1 integron found in Morganella morganii isolates from Buenos Aires, Argentina, J Antimicrob Chemother, 55, 461, 10.1093/jac/dkh556 Sompolinsky, 2005, Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel, J Antimicrob Chemother, 55, 119, 10.1093/jac/dkh517 Boyd, 2004, Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada, Antimicrob Agents Chemother, 48, 3758, 10.1128/AAC.48.10.3758-3764.2004 Jenks, 1995, Plasmid-mediated production of class I (AmpC) β-lactamase by two Klebsiella pneumoniae isolates from the UK, J Antimicrob Chemother, 35, 235, 10.1093/jac/35.1.235 Payne, 1992, Characterization of the plasmid mediated beta-lactamase BIL-1, J Antimicrob Chemother, 30, 119, 10.1093/jac/30.2.119 Stapleton, 1999, Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein, Antimicrob Agents Chemother, 43, 1206, 10.1128/AAC.43.5.1206 Hopkins, 2006, New plasmid-mediated AmpC β-lactamase (CMY-21) in Escherichia coli isolated in the UK, Int J Antimicrob Agents, 28, 80, 10.1016/j.ijantimicag.2006.03.020 Hanson, 2002, Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases, J Antimicrob Chemother, 49, 1011, 10.1093/jac/dkf052 Dunne, 2000, Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase, JAMA, 284, 3151, 10.1001/jama.284.24.3151 Giles, 2004, DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones, Antimicrob Agents Chemother, 48, 2845, 10.1128/AAC.48.8.2845-2852.2004 Carattoli, 2002, Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998, Antimicrob Agents Chemother, 46, 1269, 10.1128/AAC.46.5.1269-1272.2002 Batchelor, 2005, Characterisation of AmpC-mediated resistance in clinical isolates of Salmonella recovered from humans during the period 1993–2003 in England and Wales, J Clin Microbiol, 43, 2261, 10.1128/JCM.43.5.2261-2265.2005 Winokur, 2001, Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans, Antimicrob Agents Chemother, 45, 2716, 10.1128/AAC.45.10.2716-2722.2001 Briñas, 2002, Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals, Antimicrob Agents Chemother, 46, 3156, 10.1128/AAC.46.10.3156-3163.2002 Hawley, 1983, Compilation and analysis of Escherichia coli promoter DNA sequences, Nucleic Acids Res, 11, 2237, 10.1093/nar/11.8.2237 Jaurin, 1981, AmpC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type, Proc Natl Acad Sci USA, 78, 4897, 10.1073/pnas.78.8.4897 Olesen, 2004, Prevalence of β-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark, Microb Drug Resist, 10, 334, 10.1089/mdr.2004.10.334